Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AvePoint (AVPT) Payables: 2019-2025

Historic Payables for AvePoint (AVPT) over the last 5 years, with Sep 2025 value amounting to $2.5 million.

  • AvePoint's Payables fell 35.38% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year decrease of 55.35%. This contributed to the annual value of $2.4 million for FY2024, which is 69.94% up from last year.
  • Per AvePoint's latest filing, its Payables stood at $2.5 million for Q3 2025, which was up 39.48% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, AvePoint's Payables ranged from a high of $10.1 million in Q2 2021 and a low of $1.4 million during Q4 2023.
  • Moreover, its 3-year median value for Payables was $2.3 million (2025), whereas its average is $3.1 million.
  • Per our database at Business Quant, AvePoint's Payables skyrocketed by 97,069.90% in 2021 and then crashed by 79.18% in 2022.
  • Over the past 5 years, AvePoint's Payables (Quarterly) stood at $1.8 million in 2021, then decreased by 16.72% to $1.5 million in 2022, then declined by 8.89% to $1.4 million in 2023, then surged by 69.94% to $2.4 million in 2024, then crashed by 35.38% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, $1.8 million for Q2 2025, and $2.3 million during Q1 2025.